Key result
Personalized blood flow restriction therapy has the potential to limit muscle atrophy, aid in strength recovery, and reduce morbidity after limb trauma and orthopaedic surgery.
Why the study?
Does personalized blood flow restriction therapy accelerate rehabilitation after orthopaedic surgery?
Does personalized blood flow restriction therapy accelerate rehabilitation after orthopaedic surgery?
Personalized blood flow restriction therapy is emerging as a safe potential advancement to limit muscle atrophy and accelerate recovery after orthopaedic surgery.
Answers are grounded in this paper and cite their sources.
Personalized BFR may limit post-op atrophy in orthopaedics; leaves open efficacy without randomized trials.
Personalized (based on a percentage of a patient's limb occlusion pressure) blood flow restriction is emerging as a potential advancement in orthopaedic surgery. Safe application of the technology requires the use of medical devices capable of customizing the pressures applied to individual patients. In those circumstances, it is a low risk and noninvasive technique. By limiting muscle atrophy and aiding in the recovery of strength and function, it has the potential to significantly reduce the morbidity from limb trauma and surgery, and aid in achieving a substantially earlier return to full activity.
No takes yet. Share an insight, caveat, or question.
Brian J. Day (2018) conducted a review in Orthopaedic surgery and limb trauma. Personalized blood flow restriction therapy was evaluated. Personalized blood flow restriction therapy has the potential to limit muscle atrophy, aid in strength recovery, and reduce morbidity after limb trauma and orthopaedic surgery.
Synapse has enriched 10 related papers. Consider them for comparative context: